{
    "clinical_study": {
        "@rank": "99317", 
        "acronym": "TFO", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "a 12 week placebo matching tablets plus 4 sessions of a manualized cognitive restructuring intervention"
            }, 
            {
                "arm_group_label": "topiramate", 
                "arm_group_type": "Experimental", 
                "description": "a 12 week topiramate flexible dose administration plus 4 sessions of a manualized cognitive restructuring intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "It is a double blind controlled study to test the hypothesis that Topiramate is more\n      effective than placebo in the treatment of compulsive buying, during a period of 12 weeks"
        }, 
        "brief_title": "Topiramate Trial for Compulsive Buying", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Compulsive Shopping", 
        "detailed_description": {
            "textblock": "Compulsive buying is a prevalent disorder with no approved pharmacological treatment.\n      Previous reports suggest that topiramate could be useful in reducing impulsivity in\n      pathological gambling and other impulse control disorders, as well as craving in substance\n      addictions. The goal of this study was to investigate the effectiveness of topiramate\n      combined with brief cognitive restructuring in treating compulsive buying, compared with\n      just cognitive restructuring treatment+placebo."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Match criteria for compulsive buying, according to McElroy et al. (1994), confirmed\n             by semi-structured interview modeled after the Schedules for clinical assessment in\n             neuropsychiatry (SCID)\n\n          -  woman within fertility age have to be already practicing an acceptable contraception\n             method and to be negative at a pregnancy test\n\n        Exclusion Criteria:\n\n          -  illiteracy\n\n          -  pregnancy and breastfeeding for woman\n\n          -  previous history of alcohol abuse/dependence with current elevation of liver enzymes,\n             or a present diagnosis of alcohol abuse/dependence\n\n          -  past or current drug abuse/dependence, except for nicotine\n\n          -  history of current or past Fifth Edition of the Diagnostic and Statistical Manual of\n             Mental Disorders  diagnosis of bipolar disorder, schizophrenia, psychosis or any\n             neuropsychiatric condition causing cognitive impairment\n\n          -  a history of suicide attempt or acute suicide risk\n\n          -  severe depression indicated by a score higher than 30 at the beck depression\n             inventory\n\n          -  current participation on psychotherapy or use of pharmacological agent or\n             experimental dispositive for compulsive buying in the past 3 months\n\n          -  current use of psychotropic drugs, except benzodiazepines\n\n          -  cardiovascular disease including a history of heart attack, stroke, arrhythmia,\n             cardiac failure in the past 5 years. Uncontrolled high blood pressure.\n\n          -  chronic or acute renal or liver failure, as well as Retinopathy and thyroidopathy\n\n          -  a personal or family history of nephrolithiasis\n\n          -  immunodeficiency\n\n          -  any blood dyscrasia\n\n          -  contraindication or allergy to topiramate\n\n          -  history of seizures\n\n          -  dont't have a phone number for contact\n\n          -  live alone and don't have a person that can inform about the shopping behavior"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02138058", 
            "org_study_id": "Topiramate for oniomania"
        }, 
        "intervention": [
            {
                "arm_group_label": "topiramate", 
                "description": "a 4 sessions of a manualized cognitive restructuring intervention", 
                "intervention_name": "Topiramate", 
                "intervention_type": "Drug", 
                "other_name": "behavior"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "a 4 sessions of a manualized cognitive restructuring intervention", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Topiramate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "compulsive buying, compulsive shopping, topiramate", 
        "lastchanged_date": "May 12, 2014", 
        "link": {
            "description": "association", 
            "url": "http://www.associacaoviverbem.org.br"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "05404-010"
                }, 
                "name": "Associa\u00e7\u00e3o Viver Bem"
            }, 
            "investigator": {
                "last_name": "Hermano Tavares, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Double Blind Controlled Trial of Topiramate for Compulsive Buying", 
        "other_outcome": {
            "description": "The social Adjustment scale (SAS) is a self-report scale that assesses seven specific areas: work, social, life and leisure, extended family relationship, marital relationship, relationship with offsprings, domestic life and financial situation", 
            "measure": "Social adjustment", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "overall_contact": {
            "email": "hermanot@uol.com.br", 
            "last_name": "Hermano Tavares, Professor", 
            "phone": "+55-11-26617805"
        }, 
        "overall_contact_backup": {
            "email": "Cristiana_nm@yahoo.com.br", 
            "last_name": "Cristiana Nicoli de Mattos, researcher", 
            "phone": "+55-11-971827570"
        }, 
        "overall_official": {
            "affiliation": "associate", 
            "last_name": "Hermano Tavares, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "It is a revised version of the Yale-Brown Obsessive-Compulsive Scale (YBOCS), created to assess both the cognitive and behaviour of compulsive buying as well as to rate the severity of the problem", 
            "measure": "Yale-Brown Compulsive-Obsessive Scale Shopping Version", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02138058"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo", 
            "investigator_full_name": "Hermano Tavares", 
            "investigator_title": "Professor Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The CGI scale quantifies the severity of disease and the effects of treatment, as well as overall clinical improvement.", 
                "measure": "Clinical Global Impression scale (CGI)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "It was developed to provide a comprehensive side effect rating scale with well-defined and operationalized items to assess the side effects of psychopharmacological medications.", 
                "measure": "Udvalg for KliniskeUnders\u00f8gelser Side Effect Rating Scale (UKU)", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "University of Sao Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2015", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}